Mixed hematopoietic chimerism after marrow allografts. Transplantation in the ambulatory care setting

Ann N Y Acad Sci. 1999 Apr 30:872:372-5; discussion 375-6. doi: 10.1111/j.1749-6632.1999.tb08481.x.

Abstract

This paper describes the development of nonmyeloablative marrow transplant programs that have little toxicity in a canine model and their translation to patients with malignant and nonmalignant hematological diseases.

MeSH terms

  • Ambulatory Care
  • Animals
  • Autoimmune Diseases / therapy
  • Bone Marrow Transplantation / physiology*
  • Dogs
  • Hematologic Diseases / therapy
  • Hematologic Neoplasms / therapy
  • Hematopoietic Stem Cells / physiology*
  • Humans
  • Transplantation Chimera*
  • Transplantation, Homologous / physiology